Confirm governor's appointees for board of veterinary medicine
Summary
SR 45 is a Senate resolution that confirms three gubernatorial appointments to the Montana Board of Veterinary Medicine: Joshua Donald of Melville, Tia Nelson of Helena, and Garrett Ryerson of Manhattan. The resolution states that the Senate concurs in, confirms, and consents to these appointments for terms ending July 1, 2026, for Donald and Nelson, and July 1, 2027, for Ryerson.
The measure is procedural rather than substantive legislation. It does not create new regulatory requirements or amend the Montana Code Annotated; instead, it carries out the Senate’s constitutional and statutory role in approving executive branch appointments under sections 5-5-302 and 5-5-303, MCA, and recognizes the board structure established in section 2-15-1742, MCA. Its practical effect is to allow the Board of Veterinary Medicine to continue operating with confirmed members.
Impact
SR 45 affects the composition of the Montana Board of Veterinary Medicine by formally approving the governor’s nominees and enabling them to serve their appointed terms. It does not directly change licensing standards, disciplinary rules, or other veterinary regulations, but it supports the board’s authority to oversee veterinary practice, licensing, and professional conduct in the state.
Sentiment
The available voting history indicates strong, unanimous support for the resolution. It passed the Senate Agriculture, Livestock and Irrigation Committee 11-0 and was later adopted by the full Senate 50-0. The lack of recorded opposition suggests the appointments were broadly accepted and noncontroversial.
Contention
There is no recorded committee testimony or floor debate indicating substantive disagreement. Because the resolution concerns confirmation of executive appointments rather than policy change, any potential contention would likely have centered on the qualifications or suitability of the nominees, but no such objections appear in the available record. The unanimous votes suggest no notable controversy.